Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0000932471-25-000637·Keros Therapeutics, Inc.
Schedule 13G ownership disclosure
Keros Therapeutics Inc
Common Stock · CUSIP: 492327101
Event date: 2025-03-31
- Filing-level shares
- 2,566,321
- Percent of class
- 6.32%
- The Vanguard Group
Shares: 2,566,321 · Class: 6.32%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000932471-25-000637
- Form type
- SCHEDULE 13G
- Filer
- Keros Therapeutics, Inc.
- CIK
- CIK 1664710
- Filed
- Apr 30, 2025
- Reporting period
- Mar 31, 2025
- Description
- Schedule 13G beneficial ownership